2012Clinical Medicine & EngineeringRequires access

Reverse of Bleomycin-induced Pulmonary Fibrosis of Rats by the Effects of Resveratrol

Xiao Xin-zhou

Open publisher page 0 citations

Abstract

Objective To observe the reverse of bleomycin-induced pulmonary fibrosis of the rat by the effects of resveratrol.Methods Sixty male SD rats were randomly divided into control group,model group,and middle(50 mg/kg) ,high(100 mg/kg) resveratrol-treated groups.Rat pulmonary fibrosis was reproduced by an intratracheal injection of bleomycin to observe the inflammation and fibrosis in lung tissue changing,detect the hydroxyproline content in the lung tissues,and RT-PCR was used for determination of TGF-β1 mRNA in rats.Results The model group on the 17th day,in rat lung tissue,showed typical pulmonary fibrosis in the use of RES intervention group than in model group,the degree of fibrosis change reduced with time;In the model group(HYP content of 751.80 ± 22.5,996.00 ± 39.48,1 197.60 ± 105.98,P 0.05) was significantly higher than that of the control group(266.00 ± 24.08,307.00 ± 16.40,318.00 ± 18.7,P 0.05) ;High dose of RES in the intervention group at each time point HYP content(657.45 ± 18.31,514.34 ± 9.78,504.20 ± 13.16) were compared with the model group(751.80 ± 22.52,996.00 ± 39.48,1197.60 ± 105.98) decreased(P 0.05) ;The model group TGF-β1 mRNA content on the 17th day was highly expressed than the control group,the use of high dose of RES after the intervention of TGF beta1 mRNA all time points(0.788 ± 0.205,0.472 ± 0.199,0.474 ± 0.310) than those in the model group(1.000 ± 0.782,0.759 ± 0.226,0.603 ± 0.147) .Conclusion RES may reverse the pulmonary fibrosis of rats through the regulation of TGF-β1.

About this research paper

What this paper is about

Objective To observe the reverse of bleomycin-induced pulmonary fibrosis of the rat by the effects of resveratrol.Methods Sixty male SD rats were randomly divided into control group,model group,and middle(50 mg/kg) ,high(100 mg/kg) resveratrol-treated groups.Rat pulmonary fibrosis was reproduced by an intratracheal injection of bleomycin to observe the inflammation and fibrosis in lung tissue changing,detect the hydroxyproline content in the lung tissues,and RT-PCR was used for determination of TGF-β1 mRNA in rats.Results The model group on the 17th day,in rat lung tissue,showed typical pulmonary fibrosis in the use of RES intervention group than in model group,the degree of fibrosis change reduced with time;In the model group(HYP content of 751.80 ± 22.5,996.00 ± 39.48,1 197.60 ± 105.98,P 0.05) was significantly higher than that of the control group(266.00 ± 24.08,307.00 ± 16.40,318.00 ± 18.7,P 0.05) ;High dose of RES in the intervention group at each time point HYP content(657.45 ± 18.31,514.34 ± 9.78,504.20 ± 13.16) were compared with the model group(751.80 ± 22.52,996.00 ± 39.48,1197.60 ± 105.98) decreased(P 0.05) ;The model group TGF-β1 mRNA content on the 17th day was highly expressed than the control group,the use of high dose of RES after the intervention of TGF beta1 mRNA all time points(0.788 ± 0.205,0.472 ± 0.199,0.474 ± 0.310) than those in the model group(1.000 ± 0.782,0.759 ± 0.226,0.603 ± 0.147) .Conclusion RES may reverse the pulmonary fibrosis of rats through the regulation of TGF-β1.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the reverse of bleomycin-induced pulmonary fibrosis of the rat by the effects of resveratrol.Methods Sixty male SD rats were randomly divided into control group,model group,and middle(50 mg/kg) ,high(100 mg/kg) resveratrol-treated groups.Rat pulmonary fibrosis was reproduced by an intratracheal injection of bleomycin to observe the inflammation and fibrosis in lung tissue changing,detect the hydroxyproline content in the lung tissues,and RT-PCR was used for determination of TGF-β1 mRNA in rats.Results The model group on the 17th day,in rat lung tissue,showed typical pulmonary fibrosis in the use of RES intervention group than in model group,the degree of fibrosis change reduced with time;In the model group(HYP content of 751.80 ± 22.5,996.00 ± 39.48,1 197.60 ± 105.98,P 0.05) was significantly higher than that of the control group(266.00 ± 24.08,307.00 ± 16.40,318.00 ± 18.7,P 0.05) ;High dose of RES in the intervention group at each time point HYP content(657.45 ± 18.31,514.34 ± 9.78,504.20 ± 13.16) were compared with the model group(751.80 ± 22.52,996.00 ± 39.48,1197.60 ± 105.98) decreased(P 0.05) ;The model group TGF-β1 mRNA content on the 17th day was highly expressed than the control group,the use of high dose of RES after the intervention of TGF beta1 mRNA all time points(0.788 ± 0.205,0.472 ± 0.199,0.474 ± 0.310) than those in the model group(1.000 ± 0.782,0.759 ± 0.226,0.603 ± 0.147) .Conclusion RES may reverse the pulmonary fibrosis of rats through the regulation of TGF-β1.

Key concepts: Bleomycin, Hydroxyproline, Medicine, Pulmonary fibrosis, Resveratrol, Fibrosis, Lung, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Reverse of Bleomycin-induced Pulmonary Fibrosis of Rats by the Effects of Resveratrol — Research Paper | ScholarLens